MSN Labs Secures SEC Nod for Phase III Trial of Vibegron 75 mg, Excluding Refractory OAB Patients
- 02 November 2025
- 3 hours from now
Jubilant Wins Relief: Allahabad HC Bars Pharma Firms from Using Its Drug Dossier
- 02 November 2025
- 3 hours from now
Strides Pharma Science net profit rises 82 percent at Rs 131.5 crore in Q2
- 01 November 2025
- 11 hours ago
MSN Labs Gets SEC Go-Ahead to Conduct Phase IV Clinical Trial on Elagolix for Endometriosis
- 01 November 2025
- 11 hours ago
Boehringer Ingelheim Told to File Separate Phase IV Trial Plan for Empagliflozin
- 01 November 2025
- 11 hours ago
Another tragedy in Chhindwara: Infant dies after taking Ayurvedic formulation
- 01 November 2025
- 11 hours ago
Nearly 50% of Drug Inspector Posts Vacant at CDSCO, Reveals RTI Response
- 01 November 2025
- 11 hours ago
MSN Labs appoints Kalakuntla Srinivas Rao as Executive Vice President - Formulations Manufacturing Operations
- 01 November 2025
- 20 hours ago
Recent News
SR Post VACANCIES At ESIC Model Hospital Noida, Ch...
- 02 November, 2025
Pathologist's signature on medical reports not mus...
- 02 November, 2025
UP Eyes Japanese Investment: 125 Pharma Giants Inv...
- 02 November, 2025
Delhi Govt to recruit 1,593 senior resident doctor...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.









